198 related articles for article (PubMed ID: 20052460)
21. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
23. Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.
Lu YM; Shioda N; Han F; Moriguchi S; Kasahara J; Shirasaki Y; Qin ZH; Fukunaga K
Biochem Pharmacol; 2007 Dec; 74(12):1727-37. PubMed ID: 17888407
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Xie YY; Sun MM; Lou XF; Zhang C; Han F; Zhang BY; Wang P; Lu YM
J Pharmacol Sci; 2014; 125(3):274-82. PubMed ID: 25048017
[TBL] [Abstract][Full Text] [Related]
25. Scutellarin Exerts Anti-Inflammatory Effects in Activated Microglia/Brain Macrophage in Cerebral Ischemia and in Activated BV-2 Microglia Through Regulation of MAPKs Signaling Pathway.
Chen HL; Jia WJ; Li HE; Han H; Li F; Zhang XL; Li JJ; Yuan Y; Wu CY
Neuromolecular Med; 2020 Jun; 22(2):264-277. PubMed ID: 31792810
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional upregulation of calcineurin Abeta by endothelin-1 is partially mediated by calcium/calmodulin-dependent protein kinase IIdelta3 in rat cardiomyocytes.
Lu YM; Shioda N; Yamamoto Y; Han F; Fukunaga K
Biochim Biophys Acta; 2010; 1799(5-6):429-41. PubMed ID: 20215061
[TBL] [Abstract][Full Text] [Related]
27. Signaling Pathway for Endothelin-1- and Phenylephrine-Induced cAMP Response Element Binding Protein Activation in Rat Ventricular Myocytes: Role of Inositol 1,4,5-Trisphosphate Receptors and CaMKII.
Subedi KP; Son MJ; Chidipi B; Kim SW; Wang J; Kim KH; Woo SH; Kim JC
Cell Physiol Biochem; 2017; 41(1):399-412. PubMed ID: 28214885
[TBL] [Abstract][Full Text] [Related]
28. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
29. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
30. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
31. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
32. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
[TBL] [Abstract][Full Text] [Related]
33. Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.
Qian D; Tian J; Wang S; Shan X; Zhao P; Chen H; Xu M; Guo W; Zhang C; Lu R
BMC Complement Med Ther; 2022 Apr; 22(1):115. PubMed ID: 35468773
[TBL] [Abstract][Full Text] [Related]
34. Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress.
Wang Z; Yu J; Wu J; Qi F; Wang H; Wang Z; Xu Z
Life Sci; 2016 Jul; 157():200-207. PubMed ID: 26775564
[TBL] [Abstract][Full Text] [Related]
35. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
36. Suppression of diet-induced hypercholesterolemia by scutellarin in rats.
Li Q; Wu JH; Guo DJ; Cheng HL; Chen SL; Chan SW
Planta Med; 2009 Sep; 75(11):1203-8. PubMed ID: 19350483
[TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes?
Zhang T; Miyamoto S; Brown JH
Recent Prog Horm Res; 2004; 59():141-68. PubMed ID: 14749501
[TBL] [Abstract][Full Text] [Related]
38. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
[TBL] [Abstract][Full Text] [Related]
39. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy.
Henning RJ; Cuevas J
J Cardiovasc Pharmacol; 2006 Jul; 48(1):802-13. PubMed ID: 16891908
[TBL] [Abstract][Full Text] [Related]
40. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
